News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
293,982 Results
Type
Article (16230)
Company Profile (74)
Press Release (277678)
Multimedia
Podcasts (18)
Webinars (10)
Section
Business (83329)
Career Advice (2519)
Deals (13460)
Drug Delivery (60)
Drug Development (32828)
Employer Resources (114)
FDA (8809)
Job Trends (8077)
News (143085)
Policy (14222)
Tag
Academia (1587)
Accelerated approval (1)
Adcomms (11)
Allergies (50)
Alliances (21064)
ALS (37)
Alzheimer's disease (606)
Antibody-drug conjugate (ADC) (46)
Approvals (8845)
Artificial intelligence (135)
Autoimmune disease (9)
Automation (6)
Bankruptcy (114)
Best Places to Work (7070)
BIOSECURE Act (3)
Biosimilars (58)
Biotechnology (40)
Bladder cancer (53)
Brain cancer (21)
Breast cancer (191)
Cancer (1218)
Cardiovascular disease (121)
Career advice (2085)
Career pathing (34)
CAR-T (52)
Cell therapy (148)
Cervical cancer (15)
Clinical research (28163)
Collaboration (383)
Compensation (145)
Complete response letters (6)
COVID-19 (1088)
CRISPR (16)
C-suite (146)
Cystic fibrosis (47)
Data (1190)
Decentralized trials (2)
Denatured (6)
Depression (19)
Diabetes (293)
Diagnostics (4019)
Digital health (13)
Diversity (5)
Diversity, equity & inclusion (33)
Drug discovery (42)
Drug pricing (64)
Drug shortages (23)
Duchenne muscular dystrophy (44)
Earnings (26646)
Editorial (19)
Employer branding (14)
Employer resources (103)
Events (41993)
Executive appointments (512)
FDA (9540)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Frontotemporal dementia (3)
Funding (320)
Gene editing (26)
Generative AI (10)
Gene therapy (128)
GLP-1 (601)
Government (2561)
Grass and pollen (2)
Guidances (38)
Healthcare (12196)
Huntington's disease (2)
IgA nephropathy (21)
Immunology and inflammation (44)
Indications (18)
Infectious disease (1144)
Inflammatory bowel disease (53)
Inflation Reduction Act (5)
Influenza (21)
Intellectual property (35)
Interviews (424)
IPO (5476)
IRA (14)
Job creations (1300)
Job search strategy (1782)
Kidney cancer (2)
Labor market (28)
Layoffs (161)
Leadership (20)
Legal (2614)
Liver cancer (39)
Lung cancer (188)
Lymphoma (91)
Machine learning (3)
Management (39)
Manufacturing (127)
MASH (38)
Medical device (8034)
Medtech (8036)
Mergers & acquisitions (8266)
Metabolic disorders (598)
Multiple sclerosis (31)
NASH (11)
Neurodegenerative disease (31)
Neuropsychiatric disorders (10)
Neuroscience (827)
NextGen: Class of 2025 (4059)
Non-profit (3642)
Now hiring (37)
Obesity (302)
Opinion (123)
Ovarian cancer (36)
Pain (45)
Pancreatic cancer (34)
Parkinson's disease (53)
Partnered (7)
Patents (94)
Patient recruitment (59)
Peanut (29)
People (31071)
Pharmaceutical (24)
Pharmacy benefit managers (19)
Phase I (6731)
Phase II (11768)
Phase III (11395)
Pipeline (581)
Policy (54)
Postmarket research (1448)
Preclinical (2415)
Press Release (10)
Prostate cancer (68)
Psychedelics (6)
Radiopharmaceuticals (109)
Rare diseases (179)
Real estate (1948)
Recruiting (40)
Regulatory (10185)
Reports (21)
Research institute (1403)
Resumes & cover letters (422)
Rett syndrome (4)
RNA editing (1)
RSV (17)
Schizophrenia (33)
Series A (55)
Series B (30)
Service/supplier (4)
Sickle cell disease (27)
Special edition (10)
Spinal muscular atrophy (67)
Sponsored (15)
Startups (1330)
Stomach cancer (4)
Supply chain (37)
Tariffs (11)
The Weekly (12)
Vaccines (187)
Venture capitalists (14)
Weight loss (212)
Women's health (14)
Worklife (20)
Date
Today (67)
Last 7 days (406)
Last 30 days (1210)
Last 365 days (15625)
2025 (5366)
2024 (16381)
2023 (18168)
2022 (24257)
2021 (25913)
2020 (27355)
2019 (25656)
2018 (19071)
2017 (14083)
2016 (13946)
2015 (15397)
2014 (11133)
2013 (8798)
2012 (9713)
2011 (10193)
2010 (9021)
Location
Africa (497)
Alabama (26)
Alaska (4)
Arizona (93)
Arkansas (10)
Asia (13687)
Australia (2620)
California (2757)
Canada (923)
China (167)
Colorado (155)
Connecticut (131)
Delaware (74)
Europe (35028)
Florida (469)
Georgia (102)
Idaho (31)
Illinois (375)
India (13)
Indiana (191)
Iowa (2)
Japan (77)
Kansas (45)
Kentucky (20)
Louisiana (6)
Maine (29)
Maryland (419)
Massachusetts (1926)
Michigan (121)
Minnesota (164)
Mississippi (1)
Missouri (58)
Montana (7)
Nebraska (16)
Nevada (21)
New Hampshire (44)
New Jersey (985)
New Mexico (16)
New York (775)
North Carolina (552)
North Dakota (1)
Northern California (1240)
Ohio (84)
Oklahoma (8)
Oregon (18)
Pennsylvania (597)
Puerto Rico (4)
Rhode Island (19)
South America (699)
South Carolina (15)
Southern California (1011)
Tennessee (81)
Texas (488)
United States (11052)
Utah (122)
Virginia (85)
Washington D.C. (33)
Washington State (203)
West Virginia (3)
Wisconsin (46)
293,982 Results for "ascensia diabetes care".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
PHC Holdings Corporation and Senseonics Announce Appointment of Brian Hansen as President of CGM at Ascensia Diabetes Care
PHC Holdings Corporation and Senseonics Announce Appointment of Brian Hansen as President of CGM at Ascensia Diabetes Care.
February 6, 2024
·
8 min read
Press Releases
Eversense 365 and SweetSpot Integrate Software to Optimize Diabetes Care
February 26, 2025
·
8 min read
Pharm Country
Ascensia Diabetes Care and Senseonics Announce ‘The CGM for Real Life’ Campaign to Raise Awareness of How Long-Term Eversense E3 Empowers People with Diabetes
Ascensia Diabetes Care and Senseonics Holdings, Inc. have launched a new U.S. advertising and marketing campaign for Eversense® E3 CGM System.
October 9, 2023
·
4 min read
Press Releases
Tandem Diabetes Care Announces First Quarter 2025 Financial Results
April 30, 2025
·
13 min read
Press Releases
Diabetes Care Publishes Results From Prevalence Phase Of Corcept’s CATALYST Trial In People With Difficult-To-Control Type 2 Diabetes
April 21, 2025
·
4 min read
Pharm Country
Ascensia Diabetes Care Collaborates With SNAQ to Support Mealtime Decision-Making for People With Diabetes
Ascensia Diabetes Care, a global diabetes care company, maker of the CONTOUR® Blood Glucose Monitoring system portfolio and exclusive distributor of Eversense® Continuous Glucose Monitoring Systems, announces a landmark global collaboration with SNAQ, an award-winning app-based solution that offers key insights on food and nutrition for people with diabetes.
February 21, 2023
·
2 min read
Business
Senseonics and Mercy Collaborate to Improve Diabetes Population Health Management
Senseonics Holdings, Inc. in partnership with our global commercial partner, Ascensia Diabetes Care, and St. Louis-based Mercy, a leading health care system and accountable care organization, announced a first-of-its-kind relationship in a diabetes population management program.
May 13, 2024
·
8 min read
Pharm Country
Ascensia Diabetes Care Expands Payment Assistance and Simple Savings Program for Eversense E3 CGM System
Ascensia Diabetes Care, a global diabetes care company, maker of the CONTOUR® Blood Glucose Monitoring System portfolio and exclusive distributor of Eversense® Continuous Glucose Monitoring Systems, announces that it has significantly expanded Eversense PASS, a Payment Assistance and Simple Savings program designed to enhance affordability and access to the Eversense E3 CGM System.
May 9, 2023
·
3 min read
Press Releases
Tandem Diabetes Care Announces NEJM Publication of Positive Pivotal Study Outcomes with Control-IQ+ AID Technology in Type 2 Diabetes
March 19, 2025
·
10 min read
Pharm Country
ASCENSIA DIABETES CARE MARKS ONE-YEAR ANNIVERSARY OF US EVERSENSE E3 CGM LAUNCH WITH COMMERCIAL UPDATE AND INNOVATION OUTLOOK
Ascensia Diabetes Care , a global diabetes care company, maker of the CONTOUR ® Blood Glucose Monitoring (BGM) system portfolio and exclusive distributor of Eversense ® Continuous Glucose Monitoring (CGM) Systems, marks the one-year anniversary of launching Eversense ® E3 in the U.S. with a commercial update and outlook on future innovation.
April 24, 2023
·
4 min read
1 of 29,399
Next
